← Back to Search

Other

Personalized Medication for ADHD

N/A
Waitlist Available
Led By William Brinkman, MD, MEd, MSc
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up collected at study visit 1 and 4-12 weeks later at study visit 2.
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to test personalized medication experiments to help make decisions about future medication use for adolescents. The researchers believe that their intervention will increase the adolescents' involvement in decision making and reduce uncertainty about future medication

Who is the study for?
This trial is for adolescents with ADHD who are interested in exploring how personalized medication can affect their condition. It's a pilot study, meaning it's an early test to see if the approach works and is accepted by participants.
What is being tested?
The study tests a new way of using ADHD medication tailored to each individual. The goal is to involve teens more in decision-making about their treatment and reduce uncertainty regarding future medication use.
What are the potential side effects?
Since specific medications aren't listed, potential side effects cannot be detailed here. However, common ADHD medication side effects include sleep problems, decreased appetite, mood swings, and increased heart rate.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~collected at study visit 1 and 4-12 weeks later at study visit 2.
This trial's timeline: 3 weeks for screening, Varies for treatment, and collected at study visit 1 and 4-12 weeks later at study visit 2. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Behavioral Intention Questions
Decision-Making Involvement Scale
Decisional Conflict Scale (DCS)
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
All will choose one of five medication experiment options to complete.

Find a Location

Who is running the clinical trial?

Children's Hospital Medical Center, CincinnatiLead Sponsor
836 Previous Clinical Trials
6,565,277 Total Patients Enrolled
33 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
4,043 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
William Brinkman, MD, MEd, MScPrincipal InvestigatorCincinnati Children's
1 Previous Clinical Trials
85 Total Patients Enrolled
1 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
85 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
~15 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top